Insider transactions

David M Stack

CIK 1204788 · CEO and Chairman · last filed 2023-06-16

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$7.48M
Companies
5
Total Filings
123
Lifetime Open-Market Net
-$50.01M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

PCRX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
THE MEDICINES CO
8 CAMPUS DRIVE
PARSIPPANY, NJ 07054
Related Filers
Pacira BioSciences, Inc. — 71 joint filings, latest 2023-06-16
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCRX CEO and Chairman 205,077 $36.34 $7.45M -$45.50M 64 2023-06-16
CHIASMA, INC (CHMA) Delisted Director 0 $3.76 $0 $106.9K 7 2021-08-05
AMRN Director 2,000 $11.60 $23.2K -$4.09M 15 2021-06-16
BIOCLINICA INC (UWBK) Delisted Director 89,150 — — -$530.2K 31 2010-11-19
Molecular Insight Pharmaceuticals, Inc. (MIPI) Delisted Director — — — $0 4 2010-05-17

Recent Filings · Page 5 of 13

123 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-01-11 AMRN Mixed — -$1.60M EDGAR
2018-12-20 PCRX Exer (M) +12,000 $42.6K EDGAR
2018-11-19 PCRX Sell (S) −15,000 -$710.8K EDGAR
2018-10-15 PCRX Exer (M) +45,000 $130.7K EDGAR
2018-10-02 AMRN Grant (A) — $0 EDGAR
2018-08-16 PCRX Mixed −18,971 -$1.42M EDGAR
2018-06-15 PCRX Grant (A) +28,375 $0 EDGAR
2018-06-11 CHIASMA, INC (CHMA) Delisted Grant (A) — $0 EDGAR
2018-06-08 PCRX Sell (S) −18,406 -$667.8K EDGAR
2018-05-17 PCRX Mixed — -$654.3K EDGAR
Showing 41–50 of 123
Page 5 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.